Dr Rays Personal and Health Care LLC – Trademark Portfolio
Entity Type: 16
Dr Rays Personal and Health Care LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include IMTHEIA. The owner is based in Salt Lake City, UT.
4897 Kings Row Cir
Salt Lake City, UT 84117
Showing of trademarks Trademarks
Trademark Classifications
Dr Rays Personal and Health Care LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Dr Rays Personal and Health Care LLC have?
Dr Rays Personal and Health Care LLC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Dr Rays Personal and Health Care LLC file in?
Dr Rays Personal and Health Care LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Dr Rays Personal and Health Care LLC's most well-known trademarks?
Dr Rays Personal and Health Care LLC's registered trademark portfolio includes well-known marks such as IMTHEIA. These are among 1 currently registered trademark in the portfolio.
What is Dr Rays Personal and Health Care LLC's trademark registration success rate?
Dr Rays Personal and Health Care LLC has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.